Larvol Delta - CURSIG-A-Study-to-Assess-the-Efficacy-and-Safety-of-AK002-in-Subjects-With-AntihistamineResistant-Chronic-Urticaria

antolimab (AK002) - Allakos

http://clinicaltrials.gov/ct2/show/NCT03436797

May 21, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next